Clinical Trial Update: Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating temozolomide for primary central nervous system lymphoma, with the current status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Primary CNS Lymphoma | Phase 2 | Status: UNKNOWN